Clearside Biomedical

About:

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

Website: http://www.clearsidebio.com

Twitter/X: clearsidebio

Top Investors: HealthCare Royalty Partners, Perceptive Advisors, Cormorant Asset Management, Rock Springs Capital, Aju IB Investment

Description:

Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.

Total Funding Amount:

$204M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Alpharetta, Georgia, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)clearsidebio.com

Founders:

Henry F. Edelhauser, Mark Prausnitz, Samirkumar Patel

Number of Employees:

11-50

Last Funding Date:

2024-02-07

IPO Status:

Public

Industries:

© 2025 bioDAO.ai